Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

NCT00099671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Recombinant human interleukin-7

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)